NCT06695052

Brief Summary

The present study is designed to evaluate the role of simultaneous multi-modal sonographic tools-Ultrasound (US), Color Doppler Ultrasound (CDU), and Ultrasound Elastography (UE)-in determining the nature (benign or malignant) of axillary lymph nodes (ALNs) in patients with primary breast cancer. It aims to compare the diagnostic indices of each modality individually against their combined performance. Specifically, the study will assess whether adding UE to conventional gray-scale US and CDU improves diagnostic accuracy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Nov 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Nov 2024Dec 2026

First Submitted

Initial submission to the registry

November 5, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

2 years

First QC Date

November 5, 2024

Last Update Submit

November 17, 2024

Conditions

Keywords

breast cancerLymph Node Metastasismultimodal ultrasound

Outcome Measures

Primary Outcomes (4)

  • Evaluation of axillary LNs in Breast Cancer by Grey Scale Ultrasound

    Evaluate axillary lymph nodes (LNs) in breast cancer patients using grey scale ultrasound to assess specific characteristics such as size, shape, and cortical thickening. Results will be compared to Fine Needle Aspiration Cytology (FNAC) or histopathology findings.

    Baseline

  • Evaluation of axillary LNs in Breast Cancer by Color Doppler Ultrasound

    Evaluate axillary lymph nodes (LNs) in breast cancer patients using color Doppler ultrasound to assess vascularity patterns. Results will be compared to FNAC or histopathology findings.

    Baseline

  • Evaluation of axillary LNs in Breast Cancer by Elastography Ultrasound

    Evaluate axillary lymph nodes (LNs) in breast cancer patients using elastography ultrasound to measure stiffness and elasticity. Results will be compared to FNAC or histopathology findings.

    Baseline

  • Comparison of Multimodal Ultrasound Findings with Histopathology Results

    Compare the findings from grey scale ultrasound, color Doppler ultrasound, and elastography ultrasound with histopathology results to assess diagnostic accuracy for evaluating axillary lymph nodes in breast cancer.

    Baseline

Interventions

Greyscale US: grey scale ultrasound Color Doppler US: Color Doppler ultrasound Elastography US: Elastography ultrasound

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female patients with primary breast cancer and metastatic axillary LNs

You may qualify if:

  • \- Patients with primary breast cancer (BrCa) and axillary lymph nodes (ALNs) referred to the Department of Diagnostic Radiology for pre-operative assessment of presence, extent and nature of ALNs.

You may not qualify if:

  • Patients with secondary or recurrent Breast Ca
  • Patients exposed to loco-regional radio- or chemotherapy
  • Patients with previous axilla surgery
  • ± Patients with confirmed metastatic tumor to bone, liver and/or lungs
  • Patients who deny or refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Tsai WC, Lin CK, Wei HK, Yu BL, Hung CF, Cheng SH, Chen CM. Sonographic elastography improves the sensitivity and specificity of axilla sampling in breast cancer: a prospective study. Ultrasound Med Biol. 2013 Jun;39(6):941-9. doi: 10.1016/j.ultrasmedbio.2012.12.013. Epub 2013 Mar 7.

    PMID: 23465139BACKGROUND
  • DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.

    PMID: 31577379BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsLymphatic Metastasis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesNeoplasm MetastasisNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Abul Hassan H Mohammed, AP.radiology

    Assiut University

    STUDY DIRECTOR
  • Sara M Ahmed, AP.radiology

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Heba Abo EM Ahmed, AL.Radiology

CONTACT

Nagham N Omar, P. Radiology

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

November 5, 2024

First Posted

November 19, 2024

Study Start

November 20, 2024

Primary Completion (Estimated)

November 20, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

November 19, 2024

Record last verified: 2024-11